EDAP TMS reported EUR50.36M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AngioDynamics USD 161.35M 4.69M Sep/2025
Boston Scientific USD 8.16B 192M Sep/2026
EDAP TMS EUR 50.36M 6.01M Mar/2026
Henry Schein USD 4.78B 176M Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Veracyte USD 467.88M 106.9M Sep/2026